News | May 16, 2024
Cipla invests additional Rs. 26 crore in Achira
Achira is engaged in development and commercialization of PoC medical test kits in India
Achira is engaged in development and commercialization of PoC medical test kits in India
Cipla will be responsible for the distribution of Sanofi India's six CNS brands including Frisium
Point-of-Care solution to facilitate clinicians in quick and effective decision making
This investment will facilitate a Cipla entity's strategic participation in the Poe diagnostics and AMR space through the design, development, and manufacturing of microfluidics-based technologies
The company will donate 5000 nebulizers to primary health care centres in rural India
In some countries such as France, Italy, Spain and the Balkan region, Menarini Group will lead the commercialisation effort, as part of an exclusive licensing agreement signed with Glenmark
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)